688765 禾元生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-1.250-8.976-22.711-22.984-32.075
总资产报酬率 ROA (%)-0.982-6.592-14.957-18.109-26.042
投入资产回报率 ROIC (%)-1.117-7.663-18.269-21.466-31.449

边际利润分析
销售毛利率 (%)42.03737.09163.48954.26963.587
营业利润率 (%)-374.769-329.301-600.283-770.655-1,060.405
息税前利润/营业总收入 (%)-373.065-316.661-588.876-790.906-1,181.568
净利润/营业总收入 (%)-374.382-328.109-600.283-770.533-1,071.488

收益指标分析
经营活动净收益/利润总额(%)113.383113.440111.598107.861102.413
价值变动净收益/利润总额(%)-11.875-0.5780.0000.0000.000
营业外收支净额/利润总额(%)-0.103-0.3630.000-0.0161.034

偿债能力分析
流动比率 (X)3.3154.7671.0202.3922.350
速动比率 (X)3.0564.5040.8052.0962.215
资产负债率 (%)21.21921.74043.36623.96418.810
带息债务/全部投入资本 (%)6.5958.10022.1039.3521.573
股东权益/带息债务 (%)1,365.2231,093.949328.494943.7786,233.151
股东权益/负债合计 (%)371.278359.988130.596317.298431.644
利息保障倍数 (X)-283.139-27.662-51.62238.82110.734

营运能力分析
应收账款周转天数 (天)4.9092.2192.4742.1662.415
存货周转天数 (天)2,146.2161,012.3561,676.400995.8801,893.558